Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction
Journal of Thrombosis and Haemostasis · 2026-02 · 24 (2) · 583-597
DOI: 10.1016/j.jtha.2025.09.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-02. Verfasst von Kyota Tatsuta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Surgery, Hamamatsu University School of Me…. Hauptthemen laut MEDLINE: ADAMTS13 Protein, Intestinal Mucosa, Colitis, Ulcerative, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Precursory Research for Embryonic Science and Technology, Takeda Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation and ulceration. While von Willebrand factor, typically cleaved by ADAMTS13 from ultralarge multimers into smaller fragments, has been found to accumulate in the inflamed lesions of the ADAMTS13-deficient colitis model, the association between aberrant thrombus formation in lesional microvessels and colitis exacerbation remains unclear. OBJECTIVES: We investigated potential linkages between microthrombus formation and colitis progression. METHODS: Plasma and inflamed colonic tissues from patients with UC were analyzed. We employed intravital multiphoton microscopy to reveal the real-time structural dynamics of the mucus layer and mucosal vasculature at single-cell spatial resolution in a dextran sulfate sodium-induced colitis model of wild-type and ADAMTS13-deficient green fluorescent protein-expressing mice. RESULTS: Patients with UC exhibited significantly reduced plasma ADAMTS13 activity and excessive von Willebrand factor deposition in inflamed colonic tissues. In dextran sulfate sodium-induced colitis mice, ADAMTS13 deficiency showed heightened disease activity and increased mucosal erosion in histochemical analysis compared with wild-type mice. A novel methodology appraised colonic mucus barrier integrity by visualizing fluorescent dextran penetration from the colonic lumen to crypts. ADAMTS13 deficiency accelerated mucus layer disruption, leukocyte recruitment, and microthrombus formation, particularly in periepithelium regions. Vessel-specific analyses demonstrated that obstructive microthrombi were most prominent in the mucosal layer, contributing to local ischemia and mucosal erosion. Recombinant human ADAMTS13 alleviated microthrombus formation, improved mucosal integrity, and mitigated colitis severity in both wild-type and ADAMTS13-deficient mice. CONCLUSION: Advanced intravital imaging analysis revealed that obstructive thrombi formed in mucosal vessels due to impaired ADAMTS13 activity were essential for colitis severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan; Multidimensional Imaging Laboratory, Institute of Photonics Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japa…
- Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Internal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Förderung
- Precursory Research for Embryonic Science and Technology
- Takeda Science Foundation
- Japan Society for the Promotion of Science
- Hospital Universiti Sains Malaysia
Zitieren
APA
Tatsuta, K., Honkura, N., Morooka, N., Sakata, M., Kurachi, K., Sugimoto, K., Kokame, K., Takeuchi, H., Urano, T., & Suzuki, Y. (2026). Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction. Journal of Thrombosis and Haemostasis, 24(2), 583-597. https://doi.org/10.1016/j.jtha.2025.09.027
Vancouver
Tatsuta K, Honkura N, Morooka N, Sakata M, Kurachi K, Sugimoto K, et al. Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction. Journal of Thrombosis and Haemostasis. 2026;24(2):583-597. doi:10.1016/j.jtha.2025.09.027
BibTeX
@article{Tatsuta2026,
author = {Tatsuta, Kyota and Honkura, Naoki and Morooka, Nanami and Sakata, Mayu and Kurachi, Kiyotaka and Sugimoto, Ken and Kokame, Koichi and Takeuchi, Hiroya and Urano, Tetsumei and Suzuki, Yuko},
title = {Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {2},
pages = {583--597},
doi = {10.1016/j.jtha.2025.09.027}
}
EUVIMED